• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Glenmark Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532296
INE935A01035
855.7849313
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLENMARK
38.33
61327.88
EPS(TTM)
Face Value()
Div & Yield %
56.7
1
0.12
 

artemis electicals & projects ltd
JOJO consolidated net profit rises 7883.33% in the March 2026 quarter
May 16,2026
Net profit of JOJO rose 7883.33% to Rs 4.79 crore in the quarter ended March 2026 as against Rs 0.06 crore during the previous quarter ended March 2025. Sales rose 781.12% to Rs 12.60 crore in the quarter ended March 2026 as against Rs 1.43 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 5.62 crore in the year ended March 2026 as against net loss of Rs 1.66 crore during the previous year ended March 2025. Sales rose 446.92% to Rs 24.01 crore in the year ended March 2026 as against Rs 4.39 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales12.601.43 781 24.014.39 447
OPM %48.10-67.83 -42.69-18.45 -
PBDT5.64-0.98 LP 10.720.67 1500
PBT5.120.12 4167 9.08-0.56 LP
NP4.790.06 7883 5.62-1.66 LP